Literature DB >> 9653703

Vernix caseosa peritonitis as a rare complication of cesarean section. A case report.

O Tawfik1, J Prather, P Bhatia, J Woodroof, J Gunter, P Webb.   

Abstract

BACKGROUND: Vernix caseosa peritonitis is a rare complication of cesarean section with distinctive histopathologic findings. CASE: Vernix caseosa peritonitis occurred in a 28-year-old, pregnant woman following emergency cesarean section. Exploratory laparotomy revealed right subphrenic and perihepatic fluid collections with multiple small abdominal abscesses. Cytopathologic examination of the peritoneal lavage specimen showed a purulent inflammatory exudate admixed with occasional squamous debris, portions of hair shafts, meconium pigment, and foamy and multinucleated giant cells. During hospitalization the patient had developed Clostridium perfringens acute endometritis, presumably due to aggressive treatment with broad-spectrum antibiotics.
CONCLUSION: Pathologists are in a unique position to make the correct diagnosis in an otherwise-ambiguous clinical presentation because of the distinctive histopathologic and cytopathologic findings of this entity. Computed tomography-guided fine needle aspiration cytologic evaluation can be diagnostic in such cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653703

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

1.  Vernix caseosa peritonitis after vaginal delivery.

Authors:  Shameema A Sadath; Fathiya I Abo Diba; Surendra Nayak; Iman Al Shamali; Michael F Diejomaoh
Journal:  Clin Med Insights Case Rep       Date:  2013-10-10

2.  Vernix caseosa peritonitis - no longer rare or innocent: a case series.

Authors:  Olivia A Stuart; Alastair R Morris; Rodney J Baber
Journal:  J Med Case Rep       Date:  2009-02-10

Review 3.  Delayed presentation of vernix caseosa peritonitis.

Authors:  A C Chambers; A V Patil; R Alves; J C Hopkins; J Armstrong; R N Lawrence
Journal:  Ann R Coll Surg Engl       Date:  2012-11       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.